XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Net Sales and Profit by Segments Net sales and profit by each reportable segment for the three months ended March 31, 2023 and 2022 are as follows:
Three Months Ended March 31,
Dollars in thousands20232022
Segment Net Sales
Codman Specialty Surgical$248,136 $247,308 
Tissue Technologies
132,710 129,330 
Total revenues$380,846 $376,638 
Segment Profit
Codman Specialty Surgical$110,933 $110,160 
Tissue Technologies
52,281 53,893 
Segment profit163,214 164,053 
Amortization(3,108)(3,894)
Corporate and other(123,724)(113,995)
Operating income$36,382 $46,164 
Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
Dollars in thousands20232022
United States$271,002 $263,351 
Europe41,064 43,744 
Asia Pacific50,473 47,717 
Rest of World18,307 21,826 
Total Revenues$380,846 $376,638 
Schedule of Geographic Revenue by Area Net sales and profit by each reportable segment for the three months ended March 31, 2023 and 2022 are as follows:
Three Months Ended March 31,
Dollars in thousands20232022
Segment Net Sales
Codman Specialty Surgical$248,136 $247,308 
Tissue Technologies
132,710 129,330 
Total revenues$380,846 $376,638 
Segment Profit
Codman Specialty Surgical$110,933 $110,160 
Tissue Technologies
52,281 53,893 
Segment profit163,214 164,053 
Amortization(3,108)(3,894)
Corporate and other(123,724)(113,995)
Operating income$36,382 $46,164 
Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
Dollars in thousands20232022
United States$271,002 $263,351 
Europe41,064 43,744 
Asia Pacific50,473 47,717 
Rest of World18,307 21,826 
Total Revenues$380,846 $376,638